Author Interviews, Breast Cancer, Mammograms / 22.05.2025
Family History of Breast Cancer: Study Compares Tomosynthesis vs Mammography
MedicalResearch.com Interview with:
[caption id="attachment_68644" align="alignleft" width="200"]
Dr Tong Li[/caption]
Dr Tong Li PhD | Cancer Institute NSW Early Career Fellow
Breast Cancer Clinical and Population Health Stream
The Daffodil Centre, Faculty of Medicine and Health, The University of Sydney
Moore Theological College | The University of Sydney | NSW | 2042
MedicalResearch.com: What is the background for this study?
Response: Having a family history of breast cancer is one of the most common risk factors for women. About 8% to 11% of women in the U.S. report having a close relative diagnosed with breast cancer. These women often have dense breasts. Dense breast tissue can make standard digital mammography (DM, also known as 2D mammography) less effective in detecting cancer. Digital breast tomosynthesis (DBT), a 3D imaging technology, has become increasingly used in breast cancer screening because it improves the visibility of lesions and reduces unnecessary callbacks. However, until now, it has been unclear whether DBT offers the same benefits in women with a family history of breast cancer, especially across different family risk levels and breast density types.
Dr Tong Li[/caption]
Dr Tong Li PhD | Cancer Institute NSW Early Career Fellow
Breast Cancer Clinical and Population Health Stream
The Daffodil Centre, Faculty of Medicine and Health, The University of Sydney
Moore Theological College | The University of Sydney | NSW | 2042
MedicalResearch.com: What is the background for this study?
Response: Having a family history of breast cancer is one of the most common risk factors for women. About 8% to 11% of women in the U.S. report having a close relative diagnosed with breast cancer. These women often have dense breasts. Dense breast tissue can make standard digital mammography (DM, also known as 2D mammography) less effective in detecting cancer. Digital breast tomosynthesis (DBT), a 3D imaging technology, has become increasingly used in breast cancer screening because it improves the visibility of lesions and reduces unnecessary callbacks. However, until now, it has been unclear whether DBT offers the same benefits in women with a family history of breast cancer, especially across different family risk levels and breast density types.
